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Abstract: Background: Several studies demonstrate that the provision of personalized lifestyle
advice, based on genetics, can help motivate individuals to engage in greater nutrition and physical
activity changes compared to the provision of population-based advice. The theoretical mechanism
behind this phenomenon is poorly understood. The objective of this study was to determine the
impact of providing genetically tailored and population-based lifestyle advice on key constructs of
the Theory of Planned Behaviour (TPB). Materials and Methods: A pragmatic, cluster randomized
controlled trial (n = 140) took place at the East Elgin Family Health Team, in Aylmer, Ontario,
Canada. Participants were primarily Caucasian females enrolled in a weight management program
(BMI ≥ 25.0 kg/m2 ). Weight management program groups were randomized (1:1) to receive a
population-based lifestyle intervention for weight management (Group Lifestyle Balance™ (GLB)) or
a lifestyle genomics (LGx)-based lifestyle intervention for weight management (GLB+LGx). Attitudes,
subjective norms and perceived behavioural control were measured at baseline, immediately after
receiving a report of population-based or genetic-based recommendations and after 3-, 6- and
12-month follow-ups. Linear mixed models were conducted, controlling for measures of actual
behavioural control. All analyses were intention-to-treat by originally assigned groups. Results:
Significant changes (p < 0.05) in attitudes, subjective norms, and perceived behavioural control
tended to be short-term in the GLB group and long-term for the GLB+LGx group. Short-term and
long-term between-group differences in measures of subjective norms were discovered, favouring the
GLB+LGx group. Conclusions: The TPB can help provide a theoretical explanation for studies
demonstrating enhanced behaviour change with genetic-based lifestyle interventions. Clinical Trial
Registration: NCT03015012.
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1. Introduction
Behaviour change theories can help provide systematic explanations for why lifestyle-related
behaviour change may or may not be observed. Established behavioural theory can and should be
used to understand why certain interventions promote changes in lifestyle habits [1]. Several validated
theories have been established to help predict human lifestyle-related behaviours [1]. The Theory
of Planned Behaviour (TPB) is one of the most widely accepted behavioural theories, and suggests
that attitudes, subjective norms and perceived behavioural control are significant predictors of one’s
intention to engage in behaviours [2,3]. Attitudes are informed by behavioural beliefs or the beliefs
about the likely consequences of a given behaviour. Subjective norms, or social pressures and
behaviours, are informed by normative beliefs, which refer to beliefs about the typical habits and
expectations of others. Control beliefs are considered to be perceptions about the presence or absence
of factors that may facilitate or impede certain behaviours, and these control beliefs inform perceived
behavioural control. Actual behavioural control is an important component of the TPB and refers to
the skills, resources and other requirements that assist with or are needed to perform a behaviour.
When a sufficient degree of actual behavioural control exists, intentions tend to be carried out [2,3].
Systematic reviews and meta-analyses have demonstrated that the TPB is a validated theory for
predicting nutrition and physical activity (PA) intentions and resulting behaviours [1,4,5].
It is challenging to motivate lifestyle behaviour change in clinical practice [6,7], but several studies
have demonstrated that providing genetic information and advice can help to motivate changes in
nutrition and PA among patients [8–10]. This phenomenon has yet to be explained using the TPB [11],
but researchers have called to action the incorporation of this theory into genetic testing behaviour
change research [12]. Genetically tailored lifestyle advice can be referred to as lifestyle genomics
(LGx), which is a science exploring interactions between genetics, lifestyle factors such as nutrition and
physical activity (PA) and health outcomes [11]. For example, FTO genetic variation impacts weight
loss responses to varying levels of PA [13]. Thus, genetic testing of FTO can provide guidance for
genetically tailored PA targets. Similarly, different weight loss outcomes are observed in response to
higher vs. lower protein dietary patterns, based on FTO genetic variation [14] and therefore genetic
information can help to tailor nutrition plans. With this background in mind, the purpose of the present
study was to determine the impact of providing genetically tailored and population-based lifestyle
advice for weight management on key constructs of the TPB, while further comparing TPB changes
between a group receiving population-based lifestyle advice and a group receiving genetic-based
lifestyle advice. Overall, this study aimed to help elucidate a potential theoretical explanation for
improvements in behaviour change resulting from genetic interventions.
2. Materials and Methods
Data Availability Statement: The dataset analysed is available from the corresponding author
upon reasonable request.
This study was approved by the Western University Research Ethics Board (#108511).
All participants provided written informed consent. Figure 1 provides a visual representation
of the flow of the study (Clinical Trial Registration: NCT03015012), in which data collection occurred
at baseline during a two-week run-in period, immediately after the first group session, and after 3,
6 and 12 months. Recruitment occurred between April 2017 and September 2018, with staggered
intervention cohorts occurring from May 2017 to September 2019; the trial ended in September
2019 as the sample size was exceeded with 10 randomized groups. The CONSORT checklist was
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used to guide manuscript development; a CONSORT flow diagram has been previously published
elsewhere [15]. The Nutrigenomics, Overweight/Obesity and Weight Management (NOW) Trial was a
group, pragmatic, cluster randomized controlled trial (RCT), which was incorporated into the Group
parallel-group, pragmatic, cluster randomized controlled trial (RCT), which was incorporated into
Lifestyle Balance™ (GLB) program. GLB groups were randomized 1:1 to receive either the standard
the Group Lifestyle Balance™ (GLB) program. GLB groups were randomized 1:1 to receive either the
population-based intervention or a modified GLB intervention, which included the provision of LGx
standard population-based intervention or a modified GLB intervention, which included the provision
information and advice (GLB+LGx). There were no costs associated with enrollment in either of the
of LGx information and advice (GLB+LGx). There were no costs associated with enrollment in either
interventions for the participants. Computer-generated randomization [16] was conducted by the
of the interventions for the participants. Computer-generated randomization [16] was conducted by
first author using randomly permuted blocks and group allocation was concealed for participants
the first author using randomly permuted blocks and group allocation was concealed for participants
during a two-week run-in period. Comprehensive study methods have been previously published
during a two-week run-in period. Comprehensive study methods have been previously published
elsewhere [17] and are more briefly detailed below.
elsewhere [17] and are more briefly detailed below.
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2.1. Participants and Setting
2.1. Participants and Setting
This study took place at the East Elgin Family Health Team, a primary care clinic in Aylmer,
This study took place at the East Elgin Family Health Team, a primary care clinic in Aylmer,
Ontario, Canada. Participants enrolled in the GLB program were invited to participate in the study if
Ontario, Canada. Participants enrolled in the GLB program
were invited to participate in the study if
they met the following inclusion criteria: BMI ≥25 kg/m2 , ≥18 years of age, English-speaking, willing to
2
they met the following inclusion criteria: BMI ≥25 kg/m , ≥18 years of age, English-speaking, willing
undergo genetic testing, having access to a computer with internet at least one day per week and
to undergo genetic testing, having access to a computer with internet at least one day per week and
not seeing another healthcare provider for weight loss advice outside of the study. Pregnancy and
not seeing another healthcare provider for weight loss advice outside of the study. Pregnancy and
lactation were considered exclusion criteria. The first author was responsible for enrolling participants.
lactation were considered exclusion criteria. The first author was responsible for enrolling
A sample size was calculated based on the primary outcome indicating that a total of 74 participants
participants. A sample size was calculated based on the primary outcome indicating that a total of 74
were needed (n = 37 per group) for this trial.
participants were needed (n = 37 per group) for this trial.
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curriculum [18] in which participants were given population-based information and advice,
The five randomized standard GLB groups (n = 70) followed the established GLB program
curriculum [18] in which participants were given population-based information and advice, while
focusing on following a calorie-controlled, moderate-fat (25% of calories) nutrition plan with at least
150 min of weekly moderate-intensity PA. Participants were also provided with a 1-page summary
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while focusing on following a calorie-controlled, moderate-fat (25% of calories) nutrition plan with at
least 150 min of weekly moderate-intensity PA. Participants were also provided with a 1-page summary
report of their nutrition and PA guidelines at the first group meeting, which outlined population-based
targets including acceptable macronutrient distribution ranges [19] for: protein, total fat, saturated fat,
monounsaturated fat, polyunsaturated fat, sodium, calories, snacking and physical activity. The five
randomized modified GLB+LGx groups (n = 70) followed a modified GLB program curriculum
in which participants were given genetic-based information and advice, which differed from the
advice given to the standard GLB group, while focusing on following a calorie-controlled nutrition
plan. The nutrition and PA targets were personalized based on their individual genetic variation.
For example, participants with the AA variant of FTO (rs9939609) were advised to engage in at
least 30–60 minutes daily of physical activity six days per week with muscle-strengthening activities
at least two days per week, rather than receiving the standard population-based advice to aim for
150 minutes weekly of physical activity with at least two days per week of muscle-strengthening activity.
Participants were also provided with a 1-page summary report of their nutrition and PA guidelines
at the first group meeting, which outlined genetic-based information and advice related to: protein,
total fat, saturated fat, monounsaturated fat, polyunsaturated fat, sodium, calories, snacking and
physical activity. Sample reports for both groups have been previously published [17]. As a point of
reference (i.e., to compare their current intake to their recommended intake), participants were given
the results of their baseline self-administered online food frequency questionnaire (The Past-Month
Canadian Diet History Questionnaire II), which participants completed during the run-in period.
There were three follow-up one-on-one appointments with a registered dietitian, which occurred after 3,
6 and 12 months. At these appointments, participants completed a self-administered TPB questionnaire
and lifestyle recommendations were reviewed with a registered dietitian. All group-based GLB sessions
and one-on-one appointments were conducted face-to-face.
2.3. Outcomes
Change in the TPB components (attitudes, subjective norms and perceived behavioural control)
was a pre-specified secondary outcome of the NOW trial. A TPB questionnaire was developed with
guidance from Ajzen’s Guide to Constructing a TPB Questionnaire [3] and select TPB questions included
in the present study are outlined in Figure 2. Attitudes, subjective norms and perceived behavioural
control were measured on a Likert scale from 1 through 7. Stage of change was also measured,
based on the Transtheoretical Model, using a Likert scale of 1 through 6. Actual behavioural control
was measured through questions assessed on a Likert scale of 1 through 7, education was assessed
categorically and income was assessed continuously. TPB questionnaires were administered at five time
points: during a two-week run-in period, immediately after the first group session, where participants
were given either a summary report of population-based guidelines or genetic-based guidelines, and at
3-, 6- and 12-month follow-ups.
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2.4. Statistical Analyses
Linear mixed models were used to conduct within- and between-group analyses using SPSS
version 26.0, while controlling for measures of actual behavioural control. Self-reported measures of
actual behavioural control, collected from participant surveys, included annual household income
(CDN $), perceptions about events arising in one’s day-to-day life that suddenly take up one’s free
time, perceptions about the frequency of feeling ill or tired and highest achieved level of education.
All analyses were intention-to-treat by originally assigned groups with mean value imputation
conducted for missing data. A Bonferroni correction for multiple testing was used.
3. Results
Tables 1–3 outline the specific changes in the TPB components across groups at each of the five
time points. Participants were highly motivated at baseline and there were significant increases in
stages of change from the run-in to 3-, 6- and 12-month follow-up in both the GLB and GLB+LGx
groups. This is further depicted in Figure 3.
Table 1. Change in attitudes by intervention group over 12-month follow-up.
Group

GLB

Lifestyle Factor
and TPB
Component

Attitudes towards
PA for weight
management

GLB+LGx

GLB

Attitudes towards
kcal for weight
management

GLB+LGx

GLB

GLB+LGx

GLB

Attitudes towards
dietary fat for
weight
management

Attitudes towards
protein for weight
management

GLB+LGx

GLB

GLB+LGx

GLB

GLB+LGx

Attitudes towards
the importance of
weight
management

Attitudes towards
the impact of
undergoing
genetic testing to
enhance weight
management

Run-In
(Mean ± SE,
95% CI)

Baseline
(Mean ± SE,
95% CI)

3 Months
(Mean ± SE,
95% CI)

6 Months
(Mean ± SE,
95% CI)

12 Months
(Mean ± SE,
95% CI)

5.79 ± 0.22,
5.82–6.52

6.20 ± 0.21,
5.80–6.61
(p = 0.06)

6.21 ± 0.18,
5.85–6.57
(p = 0.04)

6.33 ± 0.17,
5.98–6.67
(p < 0.01)

6.17 ± 0.18,
5.82–6.65
(p = 0.03)

5.89 ± 0.20,
5.50–6.28

6.51 ± 0.14,
6.23–6.80
(p < 0.01)

6.50 ± 0.15,
6.20–6.81
(p < 0.01)

6.63 ± 0.11,
6.42–6.85
(p < 0.01)

6.55 ± 0.11,
6.34–6.76
(p < 0.01)

6.34 ± 0.15,
6.05–6.64

6.44 ± 0.15,
6.15–6.74
(p = 0.475)

6.27 ± 0.16,
5.95–6.59
(p = 0.627)

6.41 ± 0.14,
6.13–6.70
(p = 0.583)

6.36 ± 0.14,
6.09–6.64
(p = 0.860)

6.28 ± 0.14,
6.00–6.56

6.44 ± 0.12,
6.21–6.68
(p = 0.27)

6.55 ± 0.11,
6.32–6.77
(p = 0.07)

6.53 ± 0.10,
6.34–6.73
(p = 0.05)

6.49 ± 0.09,
6.31–6.67
(p = 0.07)

6.11 ± 0.18,
5.76–6.45

6.48 ± 0.13,
6.23–6.74
(p = 0.03)

6.24 ± 0.15,
5.96–6.54
(p = 0.45)

6.36 ± 0.12,
6.13–6.61
(p = 0.13)

6.37 ± 0.12,
6.13–6.61
(p = 0.10)

6.19 ± 0.15,
5.90–6.49

6.42 ± 0.14,
6.14–6.69
(p = 0.15)

6.50 ± 0.12,
6.25–6.74
(p = 0.03)

6.48 ± 0.12
6.23–6.72
(p = 0.04)

6.39 ± 0.12,
6.13–6.62
(p = 0.14)

5.97 ± 0.16,
5.65–6.29

6.44 ± 0.14,
6.16–6.71
(p < 0.01)

6.13 ± 0.15,
5.84–6.42
(p = 0.34)

6.30 ± 0.12,
6.06–6.54
(p = 0.02)

6.23 ± 0.13,
5.98–6.49
(p = 0.05)

6.25 ± 0.15,
5.96–6.54

6.50 ± 0.13,
6.25–6.76
(p = 0.12)

6.54 ± 0.11,
6.32–6.75
(p < 0.05)

6.58 ± 0.09,
6.40–6.77
(p = 0.01)

6.48 ± 0.10,
6.28–6.67
(p = 0.07)

6.67 ± 0.12,
6.43–6.92

6.63 ± 0.12,
6.40–6.89
(p = 0.73)

6.67 ± 0.10,
6.46–6.87
(p = 0.98)

6.61 ± 0.11,
6.39–6.83
(p = 0.57)

6.60 ± 0.11,
6.39–6.82
(p = 0.43)

6.78 ± 0.11,
6.57–6.96

6.90 ± 0.08,
6.75–7.05
(p = 0.22)

6.72 ± 0.10,
6.52–6.93
(p = 0.59)

6.76 ± 0.08,
6.60–6.92
(p = 0.82)

6.68 ± 0.09,
6.50–6.89
(p = 0.22)

6.31 ± 0.22,
5.88–6.74

6.16 ± 0.22,
5.73–6.58
(p = 0.48)

6.04 ± 0.21,
5.63–6.44
(p = 0.19) *

6.16 ± 0.18,
5.81–6.52
(p = 0.42)

6.09 ± 0.18,
5.73–6.45
(p = 0.18)

6.35 ± 0.16,
6.04–6.67

6.65 ± 0.14,
6.39–6.92
(p = 0.07)

6.58 ± 0.13,
6.33–6.83
(p = 0.14) *

6.58 ± 0.12,
6.35–6.82
(p = 0.12)

6.46 ± 0.13,
6.21–6.71
(p = 0.44)

Between-Group
Analyses

NS

NS

NS

NS

NS

* p = 0.06 at 3
months (AS)

Attitudes were measured on a Likert scale of 1 (unlikely) through 7 (likely); 4 was considered neutral. Bolded values
are significantly different from run-in (pre-intervention), within groups. GLB (n = 70 with mean value imputation);
GLB+LGx (n = 70 with mean value imputation). * Significant or approaching significant differences for changes
between groups. TPB: Theory of Planned Behaviour; NS: non-significant; AS: approaching significance; PA: physical
activity; kcal: calories; GLB: Group Lifestyle Balance™; LGx: lifestyle genomics.
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Table 2. Change in subjective norms by intervention group over 12-month follow-up.
Run-In
(Mean ± SE,
95% CI)

Baseline
(Mean ± SE,
95% CI)

3 Months
(Mean ± SE,
95% CI)

6 Months
(Mean ± SE,
95% CI)

12 Months
(Mean ± SE,
95% CI)

5.90 ± 0.25,
5.40–6.40

6.11 ± 0.21,
5.70–6.52
(p = 0.36)

6.15 ± 0.21,
5.74–6.56
(p = 0.27)

6.23 ± 0.20,
5.84–6.61
(p = 0.12)

6.08 ± 0.21,
5.66–6.50
(p = 0.36)

6.25 ± 0.22,
5.82–6.68

6.08 ± 0.24,
5.61–6.55
(p = 0.45)

6.41 ± 0.20,
6.02–6.81
(p = 0.35)

6.45 ± 0.18,
6.09–6.81
(p = 0.16)

6.30 ± 0.20,
5.91–6.69
(p = 0.69)

6.71 ± 0.17,
5.84–6.50

6.25 ± 0.15,
5.95–6.56
(p = 0.619)

6.29 ± 0.15,
6.00–6.59
(p = 0.419)

6.42 ± 0.13,
6.16–6.68
(p = 0.061)

6.28 ± 0.14,
6.00–6.56
(p = 0.372)

6.39 ± 0.16,
6.06–6.71

6.18 ± 0.19,
5.80–6.57
(p = 0.29)

6.55 ± 0.14,
6.27–6.83
(p = 0.24)

6.59 ± 0.13,
6.32–6.85
(p = 0.09)

6.43 ± 0.16,
6.12–6.75
(p = 0.68)

5.36 ± 0.26,
4.85–5.87

5.15 ± 0.25,
4.65–5.65
(p = 0.44)

5.06 ± 0.24,
4.60–5.53
(p = 0.25)

5.35 ± 0.22,
4.83–5.68
(p = 0.66)

5.02 ± 0.22,
4.58–5.87
(p = 0.16)

5.28 ± 0.25,
4.80–5.77

5.15 ± 0.27,
4.61–5.70
(p = 0.64)

5.58 ± 0.22,
5.15–6.00
(p = 0.19)

5.53 ± 0.21,
5.11–5.95
(p = 0.24)

5.37 ± 0.22,
4.94–5.80
(p = 0.65)

5.43 ± 0.23,
4.96–5.89

5.33 ± 0.22,
4.90–5.76
(p = 0.71)

5.28 ± 0.21,
4.87–5.70
(p = 0.55)

5.38 ± 0.19,
5.00–5.78
(p = 0.83)

5.09 ± 0.21,
4.68–5.49
(p = 0.13)

GLB+LGx

5.42 ± 0.23,
4.96–5.88

5.07 ± 0.27,
4.54–5.60
(p = 0.19)

5.57 ± 0.21,
5.15–5.99
(p = 0.47)

5.54 ± 0.20,
5.14–5.94
(p = 0.52)

5.48 ± 0.21,
5.06–5.89
(p = 0.74)

GLB

5.86 ± 0.23,
5.40–6.31

5.85 ± 0.24,
5.39–6.32
(p = 0.99)

5.69 ± 0.22,
5.25–6.12
(p = 0.41)

5.85 ± 0.20,
5.45–6.25
(p = 0.98)

5.57 ± 0.22,
5.13–6.31
(p = 0.11) *

GLB+LGx

5.81 ± 0.22,
5.37–6.24

5.57 ± 0.23,
5.12–6.03
(p = 0.37)

5.89 ± 0.19,
5.51–6.27
(p = 0.71)

6.08 ± 0.16,
5.76–6.40
(p = 0.17)

6.01 ± 0.16,
5.70–6.33
(p = 0.24) *

GLB

5.79 ± 0.20,
5.39–6.18

5.81 ± 0.21,
5.40–6.21
(p = 0.916)

5.65 ± 0.20,
5.25–6.05
(p = 0.473)

5.80 ± 0.18,
5.45–6.16
(p = 0.907)

5.47 ± 0.20,
5.07–5.86
(p = 0.058) *

GLB+LGx

5.93 ± 0.22,
5.50–6.36

5.70 ± 0.22,
5.25–6.14
(p = 0.344)

6.03 ± 0.18,
5.67–6.39
(p = 0.631)

6.05 ± 0.17,
5.72–6.39
(p = 0.523)

6.07 ± 0.16,
5.75–6.39
(p = 0.387) *

GLB

3.92 ± 0.32,
3.29–4.56

4.33 ± 0.31,
3.73–4.94
(p = 0.16)

4.04 ± 0.28,
3.48–4.56
(p = 0.66)

4.29 ± 0.27,
3.76–482
(p = 0.12)

4.15 ± 0.27,
3.61–4.69
(p = 0.27)

GLB+LGx

3.87 ± 0.28,
3.23–4.42

3.99 ± 0.28,
3.44–4.54
(p = 0.68)

3.89 ± 0.26,
3.38–4.40
(p = 0.95)

4.14 ± 0.24,
3.66–4.61
(p = 0.27)

4.10 ± 0.25,
3.61–4.59
(p = 0.30)

GLB

3.71 ± 0.35,
3.02–4.41

4.02 ± 0.33,
3.36–4.68
(p = 0.28)

3.91 ± 0.32,
3.27–4.55
(p = 0.45)

4.26 ± 0.31,
3.65–4.87
(p = 0.02)

4.07 ± 0.32,
3.43–4.71
(p = 0.08)

GLB+LGx

4.21 ± 0.30,
3.61–4.81

4.55 ± 0.30,
3.97–5.14
(p = 0.23)

4.60 ± 0.26,
4.07–5.12
(p = 0.12)

4.55 ± 0.27,
4.01–5.09
(p = 0.15)

4.26 ± 0.26,
3.73–4.78
(p = 0.81)

GLB

3.94 ± 0.30,
3.35–4.52

4.26 ± 0.28,
3.72–4.81
(p = 0.20)

4.21 ± 0.26,
3.70–4.73
(p = 0.23)

4.34 ± 0.26,
3.83–4.86
(p = 0.06)

4.28 ± 0.26,
3.77–4.80
(p = 0.05)

4.43 ± 0.20,
4.03–4.83

4.43 ± 0.21,
4.02–4.85
(p = 0.99)

4.73 ± 0.20,
4.34–5.12
(p = 0.17)

4.83 ± 0.17,
4.51–5.16
(p = 0.03)

4.84 ± 0.18,
4.49–5.19
(p = 0.03)

4.64 ± 0.30,
4.05–5.23

4.66 ± 0.30,
4.07–5.25
(p = 0.93)

5.06 ± 0.26,
4.54–5.59
(p < 0.05)

5.02 ± 0.26,
4.51–5.54
(p = 0.05)

4.84 ± 0.27,
4.31–5.37
(p = 0.22)

4.95 ± 0.21,
4.53–5.38

5.02 ± 0.22,
4.58–5.45
(p = 0.76)

5.23 ± 0.21,
4.81–5.64
(p = 0.17)

5.42 ± 0.19,
5.04–5.80
(p < 0.01)

5.32 ± 0.19,
4.94–5.70
(p = 0.01)

Group

GLB

Lifestyle Factor
and TPB
Component

Subjective
norms: HCT
and PA

GLB+LGx

GLB

Subjective
norms: HCT
and nutrition

GLB+LGx

GLB

Subjective
norms: Friends
and PA

GLB+LGx

GLB

Subjective
norms: Friends
and nutrition

Subjective
norms: Family
and PA

Subjective
norms: Family
and nutrition

Perception that
friends exercise
regularly

Perception that
family exercises
regularly

Perception that
friends eat a
healthy diet

GLB+LGx

GLB

GLB+LGx

Perception that
family eats a
healthy diet

Between-Group
Analyses

NS

NS

NS

NS

* p = 0.049 at 12
months

* p = 0.050 at 12
months(AS)

NS

NS

NS

NS
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Table 2. Cont.
Perception that
HCT believes
that genetic
testing will help
with weight
management

5.72 ± 0.23,
5.27–6.17

5.63 ± 0.23,
5.18–6.09
(p = 0.72)

5.59 ± 0.21,
5.19–6.00
(p = 0.55)

5.72 ± 0.19,
5.34–6.09
(p = 0.98)

5.67 ± 0.20,
5.27–6.07
(p = 0.81)

6.11 ± 0.20,
5.72–6.50

5.91 ± 0.22,
5.48–6.34
(p = 0.37)

6.36 ± 0.16,
6.04–6.67
(p = 0.15)

6.32 ± 0.15,
6.02–6.63
(p = 0.17)

6.06 ± 0.20,
5.67–6.45
(p = 0.77)

4.93 ± 0.29,
4.35–5.51

4.66 ± 0.29,
4.10–5.23
(p = 0.34)

4.38 ± 0.27,
3.84–4.92
(p = 0.04) *

4.80 ± 2.54,
4.30–5.31
(p = 0.59)

4.53 ± 0.26,
4.01–5.05
(p = 0.06)

4.92 ± 0.27,
4.39–5.46

4.71 ± 0.28,
4.15–5.23
(p = 0.46)

5.18 ± 0.24,
4.71–5.66
(p = 0.28) *

5.24 ± 0.23,
4.79–5.68
(p = 0.15)

4.99 ± 0.22,
4.55–5.43
(p = 0.71)

5.16 ± 0.29,
4.59–5.72

4.92 ± 0.27,
4.39–5.45
(p = 0.40)

4.86 ± 0.25,
4.37–5.35
(p = 0.26)

5.13 ± 0.23,
4.68–5.58
(p = 0.91)

4.81 ± 0.25,
4.31–5.31
(p = 0.14) *

5.16 ± 0.25,
4.65–5.66

5.26 ± 0.25,
4.76–5.75
(p = 0.72)

5.50 ± 0.22,
5.06–5.94
(p = 0.16)

5.67 ± 0.21,
5.27–6.08
(p = 0.02)

5.40 ± 0.19,
5.03–5.77
(p = 0.19) *

6.31 ± 0.16,
5.99–6.62

6.08 ± 0.17,
5.74–6.41
(p = 0.20)

6.32 ± 0.14,
6.05–6.59
(p = 0.95)

6.41 ± 0.12,
6.18–6.65
(p = 0.41)

6.38 ± 0.12,
6.15–6.61
(p = 0.53)

GLB+LGx

6.52 ± 0.14,
6.25–6.79

6.52 ± 0.13,
6.25–6.78
(p = 0.96)

6.55 ± 0.13,
6.29–6.81
(p = 0.86)

6.66 ± 0.10,
6.45–6.86
(p = 0.25)

6.50 ± 0.14,
6.22–6.78
(p = 0.87)

GLB

3.19 ± 0.34,
2.51–3.86

3.50 ± 0.34,
2.83–4.17
(p = 0.31)

3.43 ± 0.32,
2.80–4.05
(p = 0.39)

3.41 ± 0.31,
2.80–4.00
(p = 0.38)

3.40 ± 0.30,
2.79–4.00
(p = 0.33)

GLB+LGx

3.49 ± 0.32,
2.85–4.13

3.38 ± 0.33,
2.72–4.04
(p = 0.74)

3.50 ± 0.30,
2.91–4.10
(p = 0.97)

3.62 ± 0.29,
3.05–4.20
(p = 0.63)

3.71 ± 0.28,
3.15–4.28
(p = 0.35)

GLB

4.70 ± 0.37,
3.97–5.44

4.94 ± 0.37,
4.21–5.67
(p = 0.42)

4.79 ± 0.37,
4.06–5.51
(p = 0.76)

4.65 ± 0.35,
3.95–5.36
(p = 0.80)

4.65 ± 0.36,
3.95–5.36
(p = 0.78)

4.58 ± 0.39,
3.80–5.36

4.53 ± 0.37,
3.79–5.27
(p = 0.89)

4.67 ± 0.34,
4.00–5.35
(p = 0.78)

4.66 ± 0.33,
4.01–5.31
(p = 0.80)

4.76 ± 0.32,
4.13–5.40
(p = 0.47)

GLB

GLB+LGx

GLB

GLB+LGx

GLB

GLB+LGx

GLB

Perception that
friends believe
that genetic
testing will help
with weight
management
Perception that
family believes
that genetic
testing will help
with weight
management

Importance of
following HCT’s
advice

Importance of
following
friends’ advice

Importance of
following
family’s advice

GLB+LGx

NS

* p = 0.024 at 3
months

* p = 0.05 at 12
months (AS)

NS

NS

NS

Subjective norms were measured on a Likert scale of 1 (disagree) through 7 (agree); 4 was considered neutral.
Bolded values are significantly different from run-in (pre-intervention), within groups. GLB (n = 70 with mean value
imputation); GLB+LGx (n = 70 with mean value imputation). * Significant or approaching significant differences for
changes between groups. TPB: Theory of Planned Behaviour; NS: non-significant; AS: approaching significance;
HCT: healthcare team; kcal: calories; GLB: Group Lifestyle Balance™; LGx: lifestyle genomics.

Table 3. Change in perceived behavioural control by intervention group over 12-month follow-up.

Group

GLB

GLB+LGx

GLB

GLB+LGx

Lifestyle
Run-In
Factor and
(Mean ± SE,
TPB
95% CI)
Component
Perceived
difficulty
changing
PA

Perceived
difficulty
changing
kcal intake

Baseline
(Mean ± SE,
95% CI)

3-Months
(Mean ± SE,
95% CI)

6-Month
(Mean ± SE,
95% CI)

12-Months
(Mean ± SE,
95% CI)

4.05 ± 0.25,
4.09–5.07

4.19 ± 0.26,
3.68–4.70
(p = 0.60)

4.79 ± 0.24,
4.32–5.26
(p < 0.01)

4.63 ± 0.22,
4.19–5.07
(p < 0.01)

4.58 ± 0.25,
4.09–5.07
(p = 0.02)

4.43 ± 0.24,
3.96–4.89

4.78 ± 0.24,
4.30–5.36
(p = 0.15)

5.02 ± 0.22,
4.58–5.46
(p = 0.01)

5.01 ± 0.21,
4.58–5.43
(p < 0.01)

5.15 ± 0.20,
4.75–5.55
(p < 0.01)

4.16 ± 0.233

4.32 ± 0.22,
3.89–4.76
(p = 0.49)

4.81 ± 0.20,
4.42–5.19
(p < 0.01)

4.82 ± 0.20,
4.44–5.19
(p < 0.01)

4.63 ± 0.21,
4.22–5.03
(p = 0.02)

4.32 ± 0.27,
3.78–4.86

4.49 ± 0.26,
3.96–5.01
(p = 0.53)

4.74 ± 0.24,
4.6–5.22
(p = 0.07)

4.73 ± 0.23
4.27–5.18
(p < 0.05)

4.68 ± 0.22,
4.24–5.12
(p = 0.03)

Between-Group
Analyses

NS

NS
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Table 3. Cont.
GLB

GLB+LGx

GLB

GLB+LGx

GLB

GLB+LGx

Perceived
difficulty
changing
dietary fat
intake

4.35 ± 0.25,
3.86–4.84

4.33 ± 0.23,
3.88–4.79
(p = 0.94)

4.90 ± 0.20,
4.49–5.30
(p = 0.01)

4.89 ± 0.20,
4.49–5.29
(p = 0.01)

4.64 ± 0.22,
4.21–5.08
(p = 0.16)

4.44 ± 0.27,
3.90–4.97

4.20 ± 0.26,
3.68–4.72
(p = 0.37)

4.75 ± 0.23,
4.30–4.72
(p = 0.16)

4.86 ± 0.23,
4.41–5.32
(p = 0.04)

4.75 ± 0.23,
4.28–5.21
(p = 0.08)

Perceived
difficulty
changing
protein
intake

4.60 ± 0.24,
4.13–5.07

4.78 ± 0.22,
4.34–5.21
(p = 0.45)

5.12 ± 0.20,
4.72–5.51
(p = 0.02)

5.04 ± 0.20,
4.64–5.43
(p = 0.04)

4.96 ± 0.21,
4.55–5.37
(p = 0.07)

4.94 ± 0.25,
4.44–5.43

4.86 ± 0.22,
4.42–5.31
(p = 0.77)

5.14 ± 0.20,
7.75–5.53
(p = 0.37)

5.23 ± 0.20,
4.84–5.62
(p = 0.16)

5.05 ± 0.21,
4.64–5.47
(p = 0.53)

3.75 ± 0.24,
3.29–4.22

4.04 ± 0,23,
3.59–4.49
(p = 0.157)

4.38 ± 0.23,
3.92–4.83
(p < 0.01)

4.44 ± 0.22,
3.98–4.89
(p < 0.01)

4.39 ± 0.22,
3.95–4.83
(p < 0.01)

4.10 ± 0.26,
3.59–4.60

4.12 ± 0.24,
3.65–4.59
(p = 0.925)

4.71 ± 0.22,
4.27–5.14
(p < 0.01)

4.53 ± 0.24,
4.06–5.00
(p = 0.04)

4.65 ± 0.22,
4.22–5.08
(p < 0.01)

Perceived
difficulty
managing
weight

NS

NS

NS

Perceived behavioural control was measured on a Likert scale of 1 (extremely difficult) through 7 (extremely easy);
4 was considered neutral. Bolded values are significantly different from run-in (pre-intervention), within groups.
GLB (n = 70 with mean value imputation); GLB+LGx (n = 70 with mean value imputation). TPB: Theory of
Planned Behaviour; NS: non-significant; PA: physical activity; kcal: calories; GLB: Group Lifestyle Balance™; LGx:
lifestyle genomics.

3.1. Summary of Sample and Baseline Data
As previously published [15], the sample consisted of primarily middle-aged, middle income,
Caucasian females and there were no unintended harms reported in this RCT. Recruitment ended
after enough participants had been recruited for ten GLB/GLB+LGx groups. Baseline descriptive data
(Tables 1–3) indicate that participants had positive attitudes towards the effectiveness of nutrition
and PA for weight management, and reported that weight management was highly important to
them. They also perceived that undergoing genetic testing would assist with weight management.
Participants had overall neutral subjective norms related to friends and family consuming a healthy
diet and engaging in PA, but perceived that their friends, family and healthcare team (HCT) believed
that it was important for them to achieve their nutrition and PA recommendations. With respect to
perceptions about friends’, families’ and their HCTs’ beliefs about the effectiveness of genetic testing
for weight management, participants overall perceived that their HCT believed that genetic testing
could assist with weight management, while perceptions on this matter from friends and family were
lesser, but still trended towards positive beliefs. The reported importance of following lifestyle advice
from friends and family was negative to neutral, while the importance of following such advice from
participants’ HCT was positive. Baseline measures of perceived behavioural control were overall
neutral, with baseline stage of change between “motivation” and “action” (short-term; <3 months).
3.2. Differences between GLB and GLB+LGx Groups
In all cases of between-group differences (for both significant (p < 0.05) and approaching significant
(p = 0.05–0.06) values) for changes in the TPB components, the standard GLB group exhibited reductions,
whereas the GLB+LGx group exhibited increases (improvements). Significant differences were observed
for changes between groups at 3 months for subjective norms related to the perception that friends
believed that LGx would help with weight management. Moreover, there were significant differences
between groups at 12 months for subjective norms related to the perception that family believed that
it was important for the participant to achieve the PA recommendations. Several between-group
differences trended towards significance with p = 0.05–0.06. After 3 months, changes in attitudes
towards the effectiveness of LGx for weight management differed between groups, favouring the

(CDN $), perceptions about events arising in one’s day-to-day life that suddenly take up one’s free
time, perceptions about the frequency of feeling ill or tired and highest achieved level of education.
All analyses were intention-to-treat by originally assigned groups with mean value imputation
conducted for missing data. A Bonferroni correction for multiple testing was used.
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3. Results

Stage of Change

GLB+LGx group. Differences were also observed between groups at 12 months for changes in subjective
norms;
participants
perceived changes
that family in
members
believed
that it was important
for the participant
Tables 1–3
outline
the specific
the TPB
components
across groups
at each of the five
to achieve their physical activity (p < 0.05) and nutrition recommendations (p = 0.05–0.06), with greater
time points. improvements
Participantsin were
highly motivated at baseline and there were significant increases in
these subjective norm scores in the GLB+LGx group compared to the standard GLB
stages of change
the run-in
toin3-,perceptions
6- and 12-month
in both
GLBtesting
and GLB+LGx
group. from
Furthermore,
changes
about familyfollow-up
members believing
thatthe
genetic
help with
weight management
differed between the GLB and GLB+LGx group at 12 months
groups. Thiswould
is further
depicted
in Figure 3.
(p = 0.05–0.06).

Figure 3. Stages of change by time point and group. Stage of change was measured on a Likert scale of

Figure 3. Stages
of change
bythe
time
point andmodel
group.
Stage
of change
was measured
on a Likert scale
1 through
6 based on
transtheoretical
(stages
of change);
1 represented
pre-contemplation,
2 represented
contemplation,
3 represented motivation,
4 represented
action
months), 5 1
represented
of 1 through
6 based
on the transtheoretical
model
(stages
of (<3
change);
represented preaction
(for
3–6
months)
and
6
represented
maintenance
(>6
months).
Asterisks
indicate
significant
contemplation, 2 represented contemplation, 3 represented motivation, 4 represented action (<3
differences from run-in (pre-intervention), within groups: p ≤ 0.001 at all time points in both groups.
months), 5 represented
action (for 3–6 months) and 6 represented maintenance (>6 months). Asterisks
GLB (n = 70 with mean value imputation): Run-In 3.50 ± 0.18 (mean ± SE), 95% CI: 3.10–3.82;
indicate significant
differences
from
run-in
(pre-intervention),
groups:
≤ 0.001
Baseline 3.76
± 0.18, 95% CI:
3.41–4.12;
3 Months*
4.15 ± 0.15, 95% CI:within
3.85–4.44;
6 Months*p4.37
± 0.17, at all time
95%
CI:
4.03–4.70;
12
Months*
4.26
±
0.19,
95%
CI:
3.89–4.63.
GLB+LGx
(n
=
70
with
mean
value
points in both groups. GLB (n = 70 with mean value imputation): Run-In 3.50 ± 0.18
(mean ± SE),
imputation): Run-In 3.77 ± 0.16 (mean ± SE), 95% CI: 3.46–4.09; Baseline 3.70 ± 0.15, 95% CI: 3.40–4.00;
95%CI: 3.10–3.82;
Baseline 3.76 ± 0.18, 95%CI: 3.41–4.12; 3 Months* 4.15 ± 0.15, 95% CI: 3.85–4.44; 6
3 Months* 4.27 ± 0.12, 95% CI: 4.02–4.51; 6 Months* 4.62 ± 0.14, 95% CI: 4.33–4.90; 12 Months* 4.70 ± 0.16,
Months* 4.3795%
± 0.17,
95%CI:GLB:
4.03–4.70;
12 Months*
4.26
± 0.19,
95%CI:
3.89–4.63. GLB+LGx (n = 70 with
CI: 4.39–5.02.
Group Lifestyle
Balance™;
LGx:
lifestyle
genomics.
mean value
imputation): Run-In 3.77 ± 0.16 (mean ± SE), 95%CI: 3.46–4.09; Baseline 3.70 ± 0.15, 95%CI:
3.3. Change in Attitudes Within Groups
3.40–4.00; 3 Months* 4.27 ± 0.12, 95%CI: 4.02–4.51; 6 Months* 4.62 ± 0.14, 95%CI: 4.33–4.90; 12 Months*
Overall, significant changes (improvements) in attitudes towards the effectiveness of the nutrition
4.70 ± 0.16,
CI: 4.39–5.02. GLB:
Groupmanagement
Lifestyle Balance™;
and95%
PA recommendations
for weight
were similarLGx:
in thelifestyle
GLB andgenomics.
GLB+LGx groups,
though changes tended to be more long-term in the GLB+LGx group.

Table 1. Change in attitudes by intervention group over 12-month follow-up.

3.4. Change in Subjective Norms Within Groups
Group

GLB

GLB+LGx

GLB
GLB+LGx

Baseline
3 Months
6 Months
12 Months
Run-In
Changes in subjective norms
also tended to be more long-term in the GLB+LGx group, Between(Mean ±
Lifestyle Factor and TPB
(Mean ±
(Mean ±
(Mean ±
(Mean
± SE, norm measures observed in this group, occurring after Group
with significant
changes in five
subjective
Component
SE, 95%
SE, 95%
SE, 95%
SE, 95%
Analyses
95%
CI)
the 6- and 12-month follow-ups.
Notably,
thereCI)
were significant
changes in subjective
CI) long-termCI)
CI)
norms related to both friends and family consuming
a healthy
diet.
By comparison,
6.21
± 0.18,
6.33 ± 0.17,the standard
6.17 ± 0.18,GLB
6.20 ± 0.21,
5.79subjective
± 0.22,
group exhibited three significant
norm
changes,
occurring
shorter
term
after
the 3- and
5.85–6.57
5.98–6.67
5.82–6.65
5.80–6.61
5.82–6.52
6-month
follow-ups.
(p = 0.04)
(p < 0.01)
(p = 0.03)
(p = 0.06)
Attitudes towards PA for
NS
weight management
6.51 ± 0.14,
6.50 ± 0.15,
6.63 ± 0.11,
6.55 ± 0.11,
5.89 ± 0.20,
6.23–6.80
6.20–6.81
6.42–6.85
6.34–6.76
5.50–6.28
(p < 0.01)
(p < 0.01)
(p < 0.01)
(p < 0.01)
6.44 ± 0.15,
6.27 ± 0.16,
6.41 ± 0.14,
6.36 ± 0.14,
6.34 ± 0.15,
6.15–6.74
5.95–6.59
6.13–6.70
6.09–6.64
Attitudes towards kcal for
6.05–6.64
NS
weight management
(p = 0.475)
(p = 0.627)
(p = 0.583)
(p = 0.860)
6.28 ± 0.14,
6.44 ± 0.12,
6.55 ± 0.11,
6.53 ± 0.10,
6.49 ± 0.09,
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3.5. Change in Perceived Behavioural Control
Both interventions appear to have affected measures of perceived behavioural control over both
the short term and the long term. There were increases in the perceived difficulty of changing protein
intake in the standard GLB group, but not the GLB+LGx group.
4. Discussion
Overall, our results indicate that the provision of genetically tailored lifestyle information and
advice tended to impact antecedents of behaviour change, more so over the long term through
within-group analyses while population-based advice tended to impact antecedents of behaviour
change more over the short term through within-group analyses (e.g., attitudes towards dietary fat
intake, perceptions that friends and family consume a healthy diet and perceptions about the impact of
genetic-based advice for weight management). These findings directly relate to previously published
NOW trial results. First, we found that the addition of LGx information and advice motivated
participants to improve their diet to a significantly greater extent than population-based advice alone
after 12-month follow-up [20]. In particular, the GLB+LGx group significantly reduced their dietary
fat intake and better adhered to dietary fat guidelines compared to the standard GLB group [20].
The results of the TPB analysis indicate that these dietary fat changes may have extended to friends
and family (social norms) as evidenced by the improvement in scores related to friends and family
eating a healthy diet among the GLB+LGx group after 6 and 12 months. Future research should
explore this phenomenon further. In addition, our previous finding that the GLB+LGx group exhibited
significantly greater improvements in body composition after 3- and 6-month follow-ups [15] relates to
the current report’s finding that attitudes towards the effectiveness of genetic-based advice for weight
management were higher in the GLB+LGx group after 3 months (approaching significance). This also
relates to the finding that friends and family had enhanced perceptions compared to baseline about the
efficacy of genetic testing to assist with weight management after 3 and 6 months in the GLB+LGx
group. The increase in perceived behavioural control for perceived difficulty changing protein intake
in the GLB group, but not the GLB+LGx group is interesting given that there was a higher and more
difficult to achieve protein targets (25–35% of calories) given to participants with the AA variant of the
FTO genotype (rs9939609) [17]. In the standard GLB group, all participants were advised to consume
10–35% of calories from protein. There were also a number of changes in TPB determinants that were
similar in the GLB and GLB+LGx groups, such as increases in the perceived difficulties about changing
physical activity, calories and managing weight overall. These findings demonstrate that these may be
more challenging behaviours for participants to engage in and outcomes to achieve, regardless of the
type of information/advice provided. Future research should continue to explore how to help patients
enrolled in weight management programs overcome these challenges.
The results of this study can also help to explain findings in the body of research exploring nutrition
and PA behaviour change resulting from genetic testing, as recently detailed in a systematic review of
LGx and lifestyle behaviour change [11]. Some studies have demonstrated that genetic testing helps
motivate lifestyle behaviour change [8–10], whereas, in contrast, others have not [21–23], although one of
these studies still reported positive changes in attitudes and perceptions towards omega-3 in the genetic
group [22]. Interestingly, there have been only four long-term (12-month) RCTs assessing changes in
nutrition in genetic interventions compared to population-based interventions [8,9,11,20,24]. All of
these RCTs have demonstrated that long-term nutrition-related behaviour change was greater with the
addition of genetic-based information/advice [8,9,20,24]. Thus, we report a potential explanation of
these long-term findings, guided by the TPB. It appears that antecedents of behaviour change tend
to be positively impacted more long term in the GLB+LGx intervention group, while changes in the
standard GLB group tend to be more short term, based on the within-group analyses. Moreover,
between-group differences in subjective norms observed at 12-month follow-up suggest that social
pressures and norms may be influencing long-term changes in lifestyle habits. Therefore, the findings
from the present study provide a potential theoretical explanation to help us to understand results
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from the current body of genetic testing behaviour change research. Indeed, population-based research
consistently indicates that nutrition interventions impact short-term dietary changes, but long-term
dietary changes remain challenging [25,26]. This has been referred to as “the adherence problem” [25].
Nutrigenetic interventions could help to mitigate this problem.
Furthermore, it was interesting to find that there were long-term improvements in perceptions
that friends and family eat a healthy diet, but only in the GLB+LGx group. Thus, we speculate that
it is possible that long-term behaviour change motivated by genetic testing could affect not only the
individual undergoing genetic testing, but could expand beyond the individual into their social groups.
This speculation is supported in the literature, with numerous studies indicating the significant impact
of social modeling and social norms on food intake [27–30]. Future LGx interventional research should
seek to explore this phenomenon further.
There are some limitations that should be noted. Intention-to-treat analyses (while still considered
the gold-standard analyses for RCTs) tend to be more conservative than other methods of analysis [31,32],
therefore actual changes over time may have been underestimated in the present study. In addition,
generalizability is limited to middle-aged females enrolled in a lifestyle change weight management
program with an average household income of approximately $73,000 CDN. Future research should
seek to replicate the current study in more diverse study populations, with health-related outcomes of
interest beyond weight management. Moreover, research suggests that eating healthfully and being
physically active are less common for people of lower socioeconomic status compared to those of higher
socioeconomic status [33,34]. It is thus possible that populations with higher income may be able to
make more lifestyle changes following the provision of LGx testing given their higher food budget
(and vice versa for lower income), and thus the TPB constructs may be affected differently depending
on income. Future research should also explore this. It should be further noted that the income of
genetic testing consumers in a pragmatic setting may be higher than those enrolled in funded research
studies (who are typically not responsible for covering the cost of tests) given that they must purchase
a test, often costing hundreds of dollars [35]. Therefore, income disparities likely exist for those who
can (and cannot) afford to undergo LGx testing. This is a topic warranting further discussion.
Given that this is the first study exploring the potential theoretical mechanism for behaviour
change resulting from personalized genetic interventions, research should continue to explore this
topic further. TPB or other theory-based questionnaires can be added to genetic-based interventional
studies assessing lifestyle behaviour change. These studies should include long-term follow-up of
at least one year, given that it appears that changes in determinants of behaviour change and actual
behaviour change resulting from genetic testing interventions tend to be more long-term [8,9,20,24],
and that strategies are needed to solve the “adherence problem” [25]. This research should also explore
which particular aspects of genetic interventions are the most motivational, and how subjective norms
impact behaviour change (or lack thereof).
Overall, the present work demonstrates that the TPB can help to explain the results from studies
exploring the impact of genetic testing on lifestyle behaviour change. These results provide a potential
theoretical explanation, demonstrating that LGx interventions tend to impact antecedents of behaviour
change more long-term, with changes in certain subjective norms being significantly greater with
a LGx-guided intervention compared to a population-based intervention. In conclusion, this study
supports the hypothesis that the TPB can help to explain why genetically tailored lifestyle information
and advice can lead to improvements in lifestyle behaviour change.
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